Targeting Cancer With Decreased Toxicity: First-Of-Its-Kind Approach To Designing Nan

[News]

Researchers at Brigham and Women's Hospital (BWH) are the first to report a new approach that integrates rational drug design with supramolecular nanochemistry in cancer treatment. Supramolecular chemistry is the development of complex chemical systems using molecular building blocks...

More... (http://www.medicalnewstoday.com/releases/247692.php)